NCT07156370View on ClinicalTrials.gov

Salivary Cortisol and Hypercortisolism in Type 2 Diabetes

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
HypercortisolismType 2 Diabetes (T2DM)
Trial Locations (1)

200233

RECRUITING

Shanghai Sixth People's Hospital, Shanghai

All Listed Sponsors
lead

Shanghai 6th People's Hospital

OTHER

NCT07156370 - Salivary Cortisol and Hypercortisolism in Type 2 Diabetes | Biotech Hunter | Biotech Hunter